Mesa Laboratories, Inc.
MLAB
$105.48
-$1.87-1.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.15% | 7.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.15% | 7.23% | |||
| Cost of Revenue | -7.77% | -0.32% | |||
| Gross Profit | 0.98% | 11.96% | |||
| SG&A Expenses | 18.82% | 4.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.69% | 2.03% | |||
| Operating Income | -65.54% | 68.82% | |||
| Income Before Tax | -134.66% | 129.91% | |||
| Income Tax Expenses | 163.25% | 302.52% | |||
| Earnings from Continuing Operations | -213.94% | 46.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -213.94% | 46.61% | |||
| EBIT | -65.54% | 68.82% | |||
| EBITDA | -37.93% | 29.48% | |||
| EPS Basic | -213.68% | 46.08% | |||
| Normalized Basic EPS | -134.59% | 129.07% | |||
| EPS Diluted | -214.77% | 44.70% | |||
| Normalized Diluted EPS | -134.79% | 128.71% | |||
| Average Basic Shares Outstanding | 0.22% | 0.36% | |||
| Average Diluted Shares Outstanding | -0.38% | 0.54% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -1.88% | -0.32% | |||